All In Biotech

Drug Trial Radar · NCT03910361

Efficacy and Safety of Evoglitin in Patients With Type 2 Diabetes and Non-alcoholic Fatty Liver Diseases

A Multicenter, Double-blind, Active-controlled, Randomized, Parallel, Phase IV Clinical Trial to Evaluate the Efficacy and Safety of Evogliptin in Patients With Type 2 Diabetes and Non-alcoholic Fatty Liver Diseases

Last checked: Nov 20, 2026Latest source record: Apr 29, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

51

Actual

Start

Apr 12, 2019

Primary completion

Jul 2, 2020

Study completion Jul 2, 2020

Sponsor

Lead sponsor
Dong-A ST Co., Ltd.Industry
Sponsor type
Industry
First posted
Apr 10, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 19 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A multicenter, double-blind, active-controlled, randomized, parallel, phase IV clinical trial to evaluate the efficacy and safety of evogliptin in patients with type 2 diabetes and non-alcoholic fatty liver diseases

Conditions

  • Type2 Diabetes
  • Non-Alcoholic Fatty Liver Disease

Interventions

  • EvogliptinDrug

    evogliptin 5mg tablet qd + placebo tablet matching to pioglitazone 15mg qd

  • PioglitazoneDrug

    pioglitazone 15mg tablet qd + placebo tablet matching to evogliptin 5mg qd

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Changes from baseline intrahepatic fat (%)Time frame: 24 weeks

Locations

7 sites in 1 country. Site status is shown where the registry gives one.

  • Samsung Medical Center

    Changwon, South Korea

  • Soonchunhyang University Hospital

    Cheonan, South Korea

  • Keimyung Dongsan University Medical Center

    Daegu, South Korea

  • Hanyang University Guri Hospital

    Guri-si, South Korea

  • Catholic University of Seoul ST.Mary's Hospital

    Seoul, South Korea

  • Seoul National University Hospital

    Seoul, South Korea

  • Severance Hospital

    Seoul, South Korea

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.